Jones v. Bradshaw

138 F. Supp. 3d 921, 2015 U.S. Dist. LEXIS 139151, 2015 WL 5965236
CourtDistrict Court, N.D. Ohio
DecidedOctober 13, 2015
DocketCASE NO. 1:03 CV 1192
StatusPublished
Cited by1 cases

This text of 138 F. Supp. 3d 921 (Jones v. Bradshaw) is published on Counsel Stack Legal Research, covering District Court, N.D. Ohio primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Jones v. Bradshaw, 138 F. Supp. 3d 921, 2015 U.S. Dist. LEXIS 139151, 2015 WL 5965236 (N.D. Ohio 2015).

Opinion

MEMORANDUM OPINION AND ORDER.

DAVID A. KATZ, UNITED STATES DISTRICT JUDGE

Before the Court in this capital habeas corpus case are the following: (1) Respondent Warden Margaret Bradshaw’s (“Respondent”) motion to transfer this case back to the Sixth Circuit Court of Appeals for final resolution of Petitioner Odraye Jones’ (“Jones”)1 petition for writ of habe-as corpus (ECF No. 190), which Jones, through counsel, opposed (ECF No. 191); (2) Jones’ motion, through counsel, to extend the discovery deadline on his lethal-injection claim (ECF No. 191), which Respondent opposed (ECF No. 192), and to which Jones replied (ECF No. 195); (3) Jones’ pro se-motion to waive his lethal-injection claim and proceed ,pro se (ECF No. 193), to which Respondent responded [923]*923(ECF No. 194); (4) Respondent’s motion to dismiss Jones’ lethal-injection claim (ECF No. .217); and (5) Jones’ motion, through counsel, to strike Respondent’s motion to dismiss, or in the alternative, memorandum in opposition to that motion (ECF No. 219), which Respondent opposed (ECF No. 220).

For the following reasons, the Court: (1) grants Respondent’s motion to transfer Jones,’, lpthal-injection claim back to the Sixth Circuit; (2) denies Jones’ motion, through counsel, to extend the discovery deadline on his lethal-injection claim; (3) dismisses Jones’ pro se motion to waive his lethal-injection claim; (4) denies Respondent’s motion to dismiss the lethal-injection claim; and (5) denies Jones’ motion, through counsel, to strike Respondent’s motion to dismiss.

I. Relevant Procedural History

This Court already has addressed several of the motions now before it in a Memorandum of Opinion and Order issued on March 25, 2015. (EOF No. 201): In that opinion, the Court recited the long and complex procedural history of Jones’ claim challenging Ohio’s lethal-injection method of execution and his repeated requests to withdraw that claim and remove his counsel. (Id. at 2-14.) Ultimately, it denied Jones’ pro se motion to proceed without counsel and held in abeyance his request to waive his lethal-injection claim and the motions related to discovery on that claim until the United States Supreme Court decided Glossip v. Gross, a case involving a challenge to Oklahoma’s lethal-injection execution protocol. (Id. at 26-27.)

The Supreme. Court issued its decision in Glossip on June 29, 2015. Glossip v. Gross, — U.S.-, 135 S.Ct. 2726, 192 L.Ed.2d 761 (2015). Shortly after, Respondent filed a motion to dismiss Jones’ lethal-injection claim. (ECF No. 217.) She argues that the .Court should grant Jones’ pro se motion to withdraw his lethal-injection claim on the ground that “Glossip makes quite clear that ‘method of execution claims’ must be brought in a civil action under Title 42 Section 1983.” (Id. at 2.) Through counsel, Jonés moved to strike the motion to dismiss, or, in the alternative, opposed it. (ECF No. 219.) Although counsel initially declined to respond to Jones’ pro se motion “[bjecause the issues ha[d] been previously raised and addressed in this matter” (ECF No. 195 at 5 n.4), in this motion, Jones’ counsel argues that Jones’ pro se motion to waive his lethal-injection'claim should be “stricken” for the same reason his. motion to proceed pro se was deniéd, because the stakes in this case are too high and the legal and factual issues, too complex (ECF No. 219 at 9-10).

II. Analysis

A. Jones’ Pro Se Motion to Waive his Lethal-Injection Claim

The Court first must determine whether to grant Jones’ pro se motion to waive his lethal-injection claim, since if it were granted, all of the other motions relating to this claim would be moot. Upon further consideration of Jones! request, the Court concludes that Jones’ motion was improvidently filed because he is represented by counsel. As the Court previously has held in this case, Jones “cannot proceed by means of hybrid representation in this matter.” (ECF No. 72 at 2.) See United States v. Mosely, 810 F.2d 93, 97 (6th Cir.1987) (holding that a criminal defendant has no right to be represented by-counsel and to represent himself at the same time, because it would confuse the jury and cause undue delay). Jones’ pro se motion to waive his lethal-injection claim, therefore, is dismissed. Additionally, since Respondent’s motion to dismiss Jones’ lethal-injeetion.elaim asks the Court [924]*924to grant Jones’ request to waive the claim, it also is denied, as is Jones’ motion, through counsel, to strike Respondent’s motion to dismiss.

B. Jones’ Motion, Through Counsel, to Continue Discovery on Jones’ Lethal-Injection Claim and Respondent’s Motion to Transfer the Claim Back to the Sixth Circuit

As explained more fully in the Court’s prior opinion on this matter, Jones also requests, but through counsel, that the Court extend the discovery deadline on his lethal-injection claim until 60 days after Ohio’s next execution so that he can conduct discovery relating to the execution. (ECF No. 191 at 8-10.)

Discovery in habeas cases is governed by Habeas Rule 6(a), which provides:

A party shall be entitled to invoke the processes of discovery available under the Federal Rules of Civil Procedure if, and to the extent that, the judge in the exercise of his discretion and for good cause shown grants leave to do so, but not otherwise. '

Habeas R. 6(a). See also Bracy v. Gramley, 520 U.S. 899, 904, 117 S.Ct. 1793, 138 L.Ed.2d 97 (1997) (a federal habeas petitioner, “unlike the usual civil litigant, is not entitled to discovery as a matter of ordinary course”). “Good cause” for discovery under Rule 6(a) exists- “only where specific allegations before the court show reason to believe that the petitioner may, if the facts are fully developed, be able to demonstrate that he is ... entitled to relief....” Id. at 908-09, 117 S.Ct. 1793 (quoting Harris v. Nelson, 394 U.S. 286, 300, 89 S.Ct. 1082, 22 L.Ed.2d 281 (1969)). The Court concludes that Jones cannot demonstrate good cause to support his request for additional discovery on his lethal-injection claim.

Respondent argues that the discovery Jones requests exceeds the scope of the Sixth Circuit’s remand in January 2009 of Jones’ lethal-injection claim “for limited discovery and factual development” of the “important question” under Baze v. Rees, 553 U.S. 35, 61, 128 S.Ct. 1520, 170 L.Ed.2d 420 (2008), “of whether Ohio’s safeguards are materially different than Kentucky’s.” (ECF No. 192 at 3 (quoting ECF No. 128; Case No. 07-3755, ECF No. 60-1 at 4).) She explains,

With this new discovery request, however, Jones’ claim has morphed from focusing on the implementation and risk of future maladministration of lethál injection (the issue in Baze) to Ohio’s past deviations from, and changes to, its lethal injection protocol and its alleged botched executions. ’ This new claim is not the type of method-of[-]execution challenge addressed in Baze,

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Ward v. Wolfenbarger
E.D. Michigan, 2020

Cite This Page — Counsel Stack

Bluebook (online)
138 F. Supp. 3d 921, 2015 U.S. Dist. LEXIS 139151, 2015 WL 5965236, Counsel Stack Legal Research, https://law.counselstack.com/opinion/jones-v-bradshaw-ohnd-2015.